BlackRock’s IBIT Leads Bitcoin ETFs With $54.8M Inflow

BlackRock’s IBIT added $54.8 million to bitcoin ETFs on July 7, helping the group post a third straight day of net inflows totaling $21.44 million.

On July 7, BlackRock’s IBIT added $54.8 million to bitcoin-focused ETFs, leading the category to a third consecutive day of net inflows totaling $21.44 million.

IBIT’s $54.8 million inflow offset outflows at other providers. Fidelity’s FBTC experienced $24.92 million in redemptions and Ark & 21Shares’ ARKB posted an $8.44 million outflow. Total traded volume for bitcoin ETFs on the day was $1.51 billion and total net assets in the category closed at $77.26 billion. The three-day inflow streak for bitcoin products has totaled more than $500 million following heavy selling in June.

Ether ETFs added $26.93 million on July 7, with the entire amount recorded in BlackRock’s ETHA. Ether ETF trading volume was $388.46 million and total net assets in the category stood at $9.53 billion. Ether products have had four consecutive sessions of inflows.

Selected altcoin ETFs also saw net inflows. HYPE ETFs registered $4.32 million, primarily into Bitwise’s BHYP; the HYPE group traded $44.68 million and held $367.62 million in net assets. Solana ETFs added $1.67 million, concentrated in Fidelity’s FSOL, with $83.89 million in traded volume and $949.75 million in net assets. XRP ETF products recorded no trading activity on the day.

Market participants described the session as cautious, noting inflows continued at a slower pace than the previous day. Bitcoin’s modest net gain reflected large inflows into IBIT alongside outflows from other funds, while ether’s gains were concentrated in a single flagship product. These inflows follow a month of substantial redemptions in June.

The material on GNcrypto is intended solely for informational use and must not be regarded as financial advice. We make every effort to keep the content accurate and current, but we cannot warrant its precision, completeness, or reliability. GNcrypto does not take responsibility for any mistakes, omissions, or financial losses resulting from reliance on this information. Any actions you take based on this content are done at your own risk. Always conduct independent research and seek guidance from a qualified specialist. For further details, please review our Terms, Privacy Policy and Disclaimers.

Articles by this author